Waystar Holding (WAY) | Financial Analysis & Statements
Waystar Holding Corp Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
303.5M
Gross Profit
210.9M
69.48%
Operating Income
59.0M
19.44%
Net Income
20.0M
6.59%
EPS (Diluted)
$0.10
Balance Sheet Metrics
Total Assets
5.8B
Total Liabilities
1.9B
Shareholders Equity
3.9B
Debt to Equity
0.49
Cash Flow Metrics
Operating Cash Flow
64.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Waystar Holding Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 943.5M | 791.0M | 704.9M | 578.6M |
| Cost of Goods Sold | 348.2M | 315.7M | 249.8M | 214.9M | 151.8M |
| Gross Profit | 751.1M | 627.8M | 541.2M | 490.0M | 426.8M |
| Gross Margin % | 68.3% | 66.5% | 68.4% | 69.5% | 73.8% |
| Operating Expenses | |||||
| Research & Development | 54.6M | 48.8M | 35.3M | 32.8M | 28.3M |
| Selling, General & Administrative | 306.6M | 268.7M | 187.4M | 184.6M | 162.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 361.3M | 317.5M | 222.7M | 217.4M | 190.4M |
| Operating Income | 249.3M | 123.7M | 142.1M | 89.4M | 60.3M |
| Operating Margin % | 22.7% | 13.1% | 18.0% | 12.7% | 10.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 77.5M | 146.3M | 205.9M | 155.3M | 127.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 171.8M | -22.5M | -63.8M | -65.9M | -66.7M |
| Income Tax | 59.7M | -3.4M | -12.5M | -14.4M | -19.6M |
| Effective Tax Rate % | 34.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 112.1M | -19.1M | -51.3M | -51.5M | -47.1M |
| Net Margin % | 10.2% | -2.0% | -6.5% | -7.3% | -8.1% |
| Key Metrics | |||||
| EBITDA | - | 310.4M | 318.6M | 272.6M | 236.4M |
| EPS (Basic) | $0.63 | $-0.13 | $-0.31 | $-0.31 | $-0.28 |
| EPS (Diluted) | $0.61 | $-0.13 | $-0.31 | $-0.31 | $-0.28 |
| Basic Shares Outstanding | 177926745 | 149915839 | 166659634 | 166659634 | 166659634 |
| Diluted Shares Outstanding | 177926745 | 149915839 | 166659634 | 166659634 | 166659634 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Waystar Holding Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 61.4M | 182.1M | 35.6M | 64.6M | 47.2M |
| Short-term Investments | 24.9M | - | - | - | - |
| Accounts Receivable | 177.0M | 145.2M | 126.1M | 107.1M | 92.2M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 3.2M | 4.0M | 30.4M | 25.3M | 846.0K |
| Total Current Assets | 308.4M | 371.0M | 222.0M | 217.9M | 166.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 13.0M | 10.8M | 13.3M | 14.7M | 3.0M |
| Goodwill | 9.3B | 7.1B | 7.2B | 7.3B | 7.5B |
| Intangible Assets | 1.3B | 1.0B | 1.2B | 1.3B | 1.5B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 102.4M | 89.4M | 72.4M | 72.8M | 47.4M |
| Total Non-Current Assets | 5.5B | 4.2B | 4.4B | 4.5B | 4.6B |
| Total Assets | 5.8B | 4.6B | 4.6B | 4.7B | 4.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 50.9M | 47.4M | 45.5M | 28.1M | 34.8M |
| Short-term Debt | 20.2M | 18.2M | 23.2M | 22.8M | 18.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | 7.3M |
| Total Current Liabilities | 218.1M | 145.6M | 123.5M | 102.2M | 110.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.5B | 1.2B | 2.2B | 2.2B | 2.3B |
| Deferred Tax Liabilities | 211.3M | 100.5M | 174.5M | 240.8M | 258.1M |
| Other Non-Current Liabilities | 692.0K | 278.0K | 2.8M | 7.0K | 4.8M |
| Total Non-Current Liabilities | 1.7B | 1.4B | 2.4B | 2.5B | 2.5B |
| Total Liabilities | 1.9B | 1.5B | 2.5B | 2.6B | 2.7B |
| Equity | |||||
| Common Stock | 1.9M | 1.7M | 1.2M | 1.2M | 2.0M |
| Retained Earnings | -108.8M | -220.9M | -201.8M | -150.4M | -99.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.9B | 3.1B | 2.0B | 2.1B | 2.1B |
| Key Metrics | |||||
| Total Debt | 1.5B | 1.3B | 2.2B | 2.3B | 2.3B |
| Working Capital | 90.3M | 225.4M | 98.6M | 115.7M | 56.6M |
Balance Sheet Composition
Waystar Holding Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 112.1M | -19.1M | -51.3M | -51.5M | -47.1M |
| Depreciation & Amortization | 140.5M | 186.6M | 176.5M | 183.2M | 176.1M |
| Stock-Based Compensation | 42.1M | 54.4M | 8.8M | 8.0M | 6.8M |
| Working Capital Changes | -45.1M | -36.1M | -36.8M | -30.9M | -32.0M |
| Operating Cash Flow | 298.5M | 130.6M | 46.4M | 92.1M | 89.6M |
| Investing Activities | |||||
| Capital Expenditures | -26.5M | -27.3M | -21.5M | -17.4M | -14.5M |
| Acquisitions | -629.5M | 0 | -40.0M | 0 | -429.8M |
| Investment Purchases | -231.3M | - | - | - | - |
| Investment Sales | 206.4M | - | - | - | - |
| Investing Cash Flow | -680.9M | -27.3M | -61.5M | -17.4M | -444.3M |
| Financing Activities | |||||
| Share Repurchases | - | -844.0K | -688.0K | -2.5M | -1.9M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 390.1M | 576.1M | 20.0M | 0 | 367.0M |
| Debt Repayment | -165.5M | -1.6B | -38.8M | -65.8M | -17.7M |
| Financing Cash Flow | 243.4M | 16.7M | -17.2M | -67.0M | 331.5M |
| Free Cash Flow | 283.2M | 142.5M | 29.9M | 85.2M | 91.9M |
| Net Change in Cash | -138.9M | 120.0M | -32.2M | 7.6M | -23.2M |
Cash Flow Trend
Waystar Holding Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
40.74
Forward P/E
13.40
Price to Book
1.23
Price to Sales
4.34
PEG Ratio
-4.48
Profitability Ratios
Profit Margin
10.20%
Operating Margin
23.63%
Return on Equity
3.22%
Return on Assets
3.16%
Financial Health
Current Ratio
1.41
Debt to Equity
38.45
Per Share Data
EPS (TTM)
$0.61
Book Value per Share
$20.25
Revenue per Share
$6.18
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| WAY | 4.8B | 40.74 | 1.23 | 3.22% | 10.20% | 38.45 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Tempus AI | 9.4B | 39.30 | 18.89 | -89.48% | -19.27% | 270.11 |
| BrightSpring Health | 9.3B | 100.33 | 5.24 | 5.92% | 1.48% | 143.60 |
| HealthEquity | 6.6B | 31.61 | 3.14 | 10.19% | 16.39% | 47.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.






